Search Results
12 results found-
CSL Behring has many decades of experience in neurology, having the first approved subcutaneous immunoglobulin therapy for CIDP. Discover more information on diagnosis, SCIG and IVIG treatment, educational resources, research and key publications in CIDP.
https://medicalaffairs.cslbehring.com/diseases-and-conditions/neurology -
Discover various educational resources CSL has to offer for neurology, including information on clinical evidence in support of Hizentra for Chronic Inflammatory Demyelinating Polyneuropathy, Hizentra SCIg administration, and updated CIDP guidelines.
https://medicalaffairs.cslbehring.com/diseases-and-conditions/neurology/education-materials -
CSL Behring has many decades of experience in neurology. Discover more about our products including Privigen® Immunoglobulin Intravenous (Human), 10%, and Hizentra® Subcutaneous Immunoglobulin (Human), 20%, the first approved SCIg therapy for CIDP.
https://medicalaffairs.cslbehring.com/diseases-and-conditions/neurology/cidp-products -
Key articles published in peer-reviewed neurology journals along with abstracts and posters presented at medical conferences by CSL Behring.
https://medicalaffairs.cslbehring.com/diseases-and-conditions/neurology/key-publications -
Explore upcoming medical conferences that CSL Behring will be attending or schedule to meet the team at an upcoming event.
https://medicalaffairs.cslbehring.com/conferences-and-events -
Discover scientific information and resources for healthcare professionals related to CSL Behring medicines.
https://medicalaffairs.cslbehring.com/products/neurology -
Discover scientific information and resources for healthcare professionals related to CSL Behring medicines.
https://medicalaffairs.cslbehring.com/diseases-and-conditions -
Discover scientific information and resources for healthcare professionals related to CSL Behring medicines.
https://medicalaffairs.cslbehring.com/key-publications -
Discover scientific information and resources for healthcare professionals related to CSL Behring medicines.
https://medicalaffairs.cslbehring.com/products -
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy:
https://medicalaffairs.cslbehring.com/-/media/medical-affairs/documents/educational-materials/hizentra_clinician-highlights_flipbook-2024_csl-medical-affairs.pdf
